bullish

LTRN: IND Clearance for LP-184 in TNBC

200 Views06 May 2025 23:00
Issuer-paid
Zacks Small-Cap Research Note for Lantern Pharma, Inc. (LTRN)
What is covered in the Full Insight:
  • Introduction to Lantern Pharma
  • FDA Clearance for LP-184
  • Clinical Trial Design
  • Mechanism of Action for LP-184
  • Overview of Triple Negative Breast Cancer
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x